The emerging nanomedicine-based technology for non-small cell lung cancer immunotherapy: how far are we from an effective treatment

Non-small cell lung cancer (NSCLC) is a prominent etiology of cancer-related mortality. The heterogeneous nature of this disease impedes its accurate diagnosis and efficacious treatment. Consequently, constant advancements in research are imperative in order to comprehend its intricate nature. In ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Lei, Xu, Quan, Yin, Sui, Zhang, Ye, Wu, Hao, Liu, Yangchun, Chen, Liru, Hu, Yeji, Yuan, Jun, Peng, Kai, Lin, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172578/
https://www.ncbi.nlm.nih.gov/pubmed/37182180
http://dx.doi.org/10.3389/fonc.2023.1153319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172578/
https://www.ncbi.nlm.nih.gov/pubmed/37182180
http://dx.doi.org/10.3389/fonc.2023.1153319

Ejemplares similares